Dr. Bhupendra Kumar Modi - 23 Sep 2022 Form 3 Insider Report for Organicell Regenerative Medicine, Inc. (ZEOX)

Reporting relationship: Director
Issuer ticker: ZEOX
Reported as of: 23 Sep 2022
Net transaction value: $0
SEC form: 3
Accepted by SEC: 03 Oct 2022, 06:00:21 UTC
Source filing: View source filing
Reporting owner signature: /s/ Dale S. Bergman as attorney-in-fact for Dr. Bhupendra Kumar Modi

Key filing fact

Dr. Bhupendra Kumar Modi filed Form 3 for Organicell Regenerative Medicine, Inc. (ZEOX) on 03 Oct 2022.

Key facts

This page summarizes Dr. Bhupendra Kumar Modi's Form 3 filing for Organicell Regenerative Medicine, Inc. (ZEOX).
0 reported transactions and 0 derivative rows are listed below.
Accepted by SEC: 03 Oct 2022, 06:00.

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Official SEC source

Ownership activity is grounded in SEC Form 3 disclosures.

Shares, units, or other non-derivative securities reported in this filing.

OCEL holding

No transaction description listed

OCEL holding

No transaction description listed

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Explanation of responses 1 footnote

Footnote F1

Reporting Person holds 100 % beneficial shareholding of Beyond 100 FZE and Smart Co. Holding Pte. Ltd.

SEC remarks

Exhibit List - Exhibit 24 Power of attorney